Data Foundry

Drug recalls 2017

ATENOLOL Tablets — Class II drug recall D-0605-2017

Terminated recall by Zydus Pharmaceuticals USA Inc, reported 2017-03-29, distributed nationwide. Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained

Recall numberD-0605-2017
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmZydus Pharmaceuticals USA Inc, Pennington, NJ, United States
Recall initiated2017-03-06
Classified2017-03-21
Reported by FDA2017-03-29
Terminated2019-11-05
DistributedNationwide (US)
Quantity9,561 bottles
NDC68382-0022, 68382-0022-01, 68382-0022-10, 68382-0022-16, 68382-0022-24, 68382-0022-40, 68382-0023, 68382-0023-01, 68382-0023-02, 68382-0023-10, 68382-0023-16, 68382-0023-24, 68382-0023-40, 68382-0024, 68382-0024-01, 68382-0024-10, 68382-0024-16, 68382-0024-40

Product

ATENOLOL Tablets, USP, 50 mg, packaged in a) 100-count bottles (NDC 68382-023-01) and b) 1000-count bottles (NDC 68382-023-10), Rx only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals USA Inc., Pennington, NJ 08534.

Reason for recall

Presence of Foreign Tablets/Capsules: Customer complaint that a bottle of atenolol 50 mg Tablets USP contained a paroxetine 20 mg tablet.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0605-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.